M&A: Scienture Holdings, Inc.

Form Type: DEF 14C

Filing Date: 2024-12-30

Corporate Action: Acquisition

Type: New

Accession Number: 000149315224052473

Comments: On December 30, 2024, Scienture Holdings, Inc. filed an Information Statement with the SEC to notify stockholders that a majority of holders executed written consents approving significant corporate actions. These actions include the issuance of over 20% of the company's outstanding common stock in two transactions: the first with Arena Finance Markets, LP (the 'SPA Issuance Proposal') dated November 22, 2024, and the second with Arena Business Solutions Global SPC II, Ltd (the 'ELOC Issuance Proposal') dated November 25, 2024. The SPA issuance involves a convertible debenture of up to $12,222,222, while the ELOC agreement allows for the purchase of up to $50 million in shares. The announcement states these approvals comply with Nasdaq Listing Rule 5635(d) regarding stockholder authorization for such issuances. The actions will become effective approximately twenty days after the mailing of this Information Statement, expected around January 7, 2025.

Document Link: View Document